These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

940 related items for PubMed ID: 15383190

  • 1. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain.
    Clark AJ, Ahmedzai SH, Allan LG, Camacho F, Horbay GL, Richarz U, Simpson K.
    Curr Med Res Opin; 2004 Sep; 20(9):1419-28. PubMed ID: 15383190
    [Abstract] [Full Text] [Related]

  • 2. Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain.
    van Seventer R, Smit JM, Schipper RM, Wicks MA, Zuurmond WW.
    Curr Med Res Opin; 2003 Sep; 19(6):457-69. PubMed ID: 14594516
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of TD-fentanyl with sustained-release morphine in the pain treatment of patients with lung cancer].
    Oztürk T, Karadibak K, Catal D, Cakan A, Tugsavul F, Cirak K.
    Agri; 2008 Jul; 20(3):20-5. PubMed ID: 19085178
    [Abstract] [Full Text] [Related]

  • 4. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.
    Pain Pract; 2008 Jul; 8(4):287-313. PubMed ID: 18503626
    [Abstract] [Full Text] [Related]

  • 5. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S, Porzio G, Ferrera P, Fulfaro F, Aielli F, Verna L, Villari P, Ficorella C, Gebbia V, Riina S, Casuccio A, Mangione S.
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [Abstract] [Full Text] [Related]

  • 6. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM, Messina J, Xie F, Hale M.
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [Abstract] [Full Text] [Related]

  • 7. The safety and efficacy of fentanyl iontophoretic transdermal system compared with morphine intravenous patient-controlled analgesia for postoperative pain management: an analysis of pooled data from three randomized, active-controlled clinical studies.
    Viscusi ER, Siccardi M, Damaraju CV, Hewitt DJ, Kershaw P.
    Anesth Analg; 2007 Nov; 105(5):1428-36, table of contents. PubMed ID: 17959978
    [Abstract] [Full Text] [Related]

  • 8. Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study.
    Sittl R, Likar R, Nautrup BP.
    Clin Ther; 2005 Feb; 27(2):225-37. PubMed ID: 15811486
    [Abstract] [Full Text] [Related]

  • 9. Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine.
    Wirz S, Wittmann M, Schenk M, Schroeck A, Schaefer N, Mueller M, Standop J, Kloecker N, Nadstawek J.
    Eur J Pain; 2009 Aug; 13(7):737-43. PubMed ID: 18977159
    [Abstract] [Full Text] [Related]

  • 10. Early conversion from oral morphine to transdermal fentanyl in patients with cancer pain.
    Tani M, Fuku A, Terashita S, Kashiwagi H, Yukawa H, Yamaue H.
    Hepatogastroenterology; 2008 Aug; 55(86-87):1545-8. PubMed ID: 19102339
    [Abstract] [Full Text] [Related]

  • 11. Predicting long-term response to strong opioids in patients with low back pain: findings from a randomized, controlled trial of transdermal fentanyl and morphine.
    Kalso E, Simpson KH, Slappendel R, Dejonckheere J, Richarz U.
    BMC Med; 2007 Dec 21; 5():39. PubMed ID: 18154644
    [Abstract] [Full Text] [Related]

  • 12. From codeine to transdermal fentanyl for cancer pain control: a safety and efficacy clinical trial.
    Mystakidou K, Befon S, Kouskouni E, Gerolymatos K, Georgaki S, Tsilika E, Vlahos L.
    Anticancer Res; 2001 Dec 21; 21(3C):2225-30. PubMed ID: 11501851
    [Abstract] [Full Text] [Related]

  • 13. Transdermal fentanyl versus sustained release oral morphine in strong-opioid naïve patients with chronic low back pain.
    Allan L, Richarz U, Simpson K, Slappendel R.
    Spine (Phila Pa 1976); 2005 Nov 15; 30(22):2484-90. PubMed ID: 16284584
    [Abstract] [Full Text] [Related]

  • 14. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
    Likar R, Lorenz V, Korak-Leiter M, Kager I, Sittl R.
    Clin Ther; 2007 Aug 15; 29(8):1591-606. PubMed ID: 17919542
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of the fentanyl iontophoretic transdermal system (ITS) and intravenous patient-controlled analgesia (IV PCA) with morphine for pain management following abdominal or pelvic surgery.
    Minkowitz HS, Rathmell JP, Vallow S, Gargiulo K, Damaraju CV, Hewitt DJ.
    Pain Med; 2007 Aug 15; 8(8):657-68. PubMed ID: 18028044
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of fentanyl HCl iontophoretic transdermal system compared with morphine intravenous patient-controlled analgesia for postoperative pain management for patient subgroups.
    Mattia C, Coluzzi F, Sonnino D, Anker-Møller E.
    Eur J Anaesthesiol; 2010 May 15; 27(5):433-40. PubMed ID: 20186064
    [Abstract] [Full Text] [Related]

  • 17. A Phase III study to assess the clinical utility of low-dose fentanyl transdermal system in patients with chronic nonmalignant pain.
    Otis J, Rothman M.
    Curr Med Res Opin; 2006 Aug 15; 22(8):1493-501. PubMed ID: 16870074
    [Abstract] [Full Text] [Related]

  • 18. Transdermal fentanyl for improvement of pain and functioning in osteoarthritis: a randomized, placebo-controlled trial.
    Langford R, McKenna F, Ratcliffe S, Vojtassák J, Richarz U.
    Arthritis Rheum; 2006 Jun 15; 54(6):1829-37. PubMed ID: 16729276
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of safety and efficacy of transdermal therapeutic system-fentanyl in adult patients with gynecological cancer-related pain.
    Lorvidhaya V, Katanyoo K, Srisomboon J, Suprapaphorn P, Cheewakriangkrai C.
    J Med Assoc Thai; 2004 Mar 15; 87(3):319-25. PubMed ID: 15117050
    [Abstract] [Full Text] [Related]

  • 20. Use of transdermal fentanyl without prior opioid stabilization in patients with cancer pain.
    Tawfik MO, Bryuzgin V, Kourteva G, FEN-INT-20 Study Group.
    Curr Med Res Opin; 2004 Mar 15; 20(3):259-67. PubMed ID: 15025835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.